Eliem Therapeutics (CLYM) Earnings (2020 - 2026)
Eliem Therapeutics (CLYM) earnings from Mar 31, 2020 to Mar 31, 2026. The TTM Eliem Therapeutics (CLYM) earnings is -$53M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Eliem Therapeutics (CLYM) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -43.21% |
| 3 Years TTM | -0.95% |
| 5 Years TTM | +7.17% |
| All Time TTM | +7.17% |
Annual Earnings change of Eliem Therapeutics (CLYM)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$14M | -77.08% |
| 2025 | -$60M | -19.01% |
| 2024 | -$74M | +110.42% |
| 2023 | -$35M | -22.37% |
| 2022 | -$45M | -4.72% |
| 2021 | -$47M | +129.70% |
| 2020 | -$21M | N/A |
Comparison Eliem Therapeutics (CLYM) five years earnings CAGR with competitors
Eliem Therapeutics (CLYM) five years earnings CAGR is 7.16%.